Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

Figure 4. Withdrawals due to adverse events: angiotensin-converting enzyme (ACE) inhibitors versus angiotensin II receptor blockers (ARBs).

The first group is observational studies and the second group is randomized, controlled trials.

Published Ahead of Print November 5, 2007, Ann Intern Med January 1, 2008 vol. 148 no. 1 16-29